Aalo manufactures compact nuclear reactors that utilize liquid metal coolant and UZrH fuel to achieve high energy density and simplified safety systems. These reactors can generate electricity at a target cost of 3¢ per kWh, providing a scalable solution for energy needs ranging from small data centers to large cities.

Ansa Biotechnologies utilizes proprietary enzymatic technology to synthesize complex DNA sequences up to 5 kb in length without the need for assembly, enabling the direct synthesis of challenging constructs such as GC-rich sequences and CRISPR arrays. This technology addresses the limitations of traditional DNA synthesis methods, allowing researchers to obtain reliable and rapid access to the complex sequences necessary for advanced scientific projects.

This company develops frontier technology to measure and modify cellular function using molecular engineering. Their platform maps biological interactions in their native context, linking cell and tissue phenotypes to underlying molecules for actionable insights. They enable functional screening and characterization of biotherapeutics and genetic medicines directly within biological systems.

Elicit is an AI platform designed to accelerate scientific research by synthesizing evidence from academic literature and clinical trials. The platform offers semantic search capabilities, automated research report generation, and systematic literature review support to help researchers quickly understand existing knowledge. By automating data extraction and literature synthesis, Elicit enables researchers across academia and industry to operate more evidence-based and efficiently.

Faction provides a driverless vehicle platform for on-demand and delivery applications using zero-emission electric vehicles. Their software suite integrates with existing order management systems to enable real-time tracking and customer interaction. This pragmatic autonomy solution allows for quick, cost-effective deployment in controlled commercial environments to optimize transport efficiency.

Provides a grid monitoring and management system that uses real-time fault detection, independent operation during outages, and condition-based asset tracking to improve utility infrastructure. This system reduces outage duration, minimizes wildfire risks, and extends asset lifespan by enabling precise maintenance and rapid response to grid failures.

This startup offers a mobile clinical assistant that helps healthcare professionals manage and treat disease-related malnutrition. The tool provides resources and support to improve patient outcomes by addressing nutritional needs.

Lively offers a Health Savings Account (HSA) platform that provides individuals and employers with a transparent, fee-free structure for managing healthcare savings. The platform simplifies benefits administration through user-friendly technology, enabling efficient contributions and personalized investment options while enhancing employee engagement and satisfaction.

Nabla Bio utilizes biologically informed machine learning and experimental technologies to design antibodies with atomic precision, targeting complex disease mechanisms such as GPCRs and ion channels. The platform enhances drug manufacturability, safety, and efficacy by integrating AI-driven design with empirical measurement of human-relevant drug properties.

Oolu provides off-grid solar home systems using a Pay-As-You-Go financing model, enabling households in West Africa to access clean and affordable energy. This technology replaces reliance on costly and inefficient kerosene lamps, allowing families to save on energy expenses while improving their quality of life through enhanced lighting and charging capabilities.

Opentrons develops the Flex, a versatile pipetting robot that automates liquid handling tasks in laboratory settings, allowing for precise transfers of 1 to 1000 μL using swappable pipettes. This technology addresses the inefficiencies of manual pipetting by enabling rapid setup and execution of experiments, thereby increasing throughput and reducing the potential for human error.

Persephone Biosciences utilizes artificial intelligence and synthetic biology to develop microbial-based immunotherapies that restore human microbiomes, addressing the health impacts of damaged ecosystems. Their approach aims to enhance therapeutic responses and improve patient outcomes in the fight against cancer.

This company provides clinical-grade metabolic testing services, including VO2 Max and Resting Metabolic Rate analysis, to healthcare professionals. Their non-invasive breath analysis yields 23 biomarkers to inform personalized treatment planning for nutrition, exercise, and recovery protocols. The platform integrates these diagnostics with a health dashboard to help clinics standardize care and improve client outcomes.

Quantstamp is a blockchain security company that provides smart contract auditing and vulnerability assessments to enhance the security of blockchain projects. By identifying and mitigating potential security risks, Quantstamp helps protect assets and maintain trust in decentralized applications.

The startup offers a customizable cellular network infrastructure that allows users to design and manage their own connectivity solutions. This approach addresses the limitations of traditional networks by providing enhanced control and flexibility, enabling users to optimize coverage and performance based on their specific needs.

Roin Technologies develops robotic systems specifically designed to automate the processes involved in commercial concrete construction, enhancing precision and efficiency. By reducing labor costs and minimizing human error, their technology addresses the challenges of labor shortages and project delays in the construction industry.

Harmonic Discovery develops a kinase inhibitor drug platform that utilizes machine learning, structural modeling, and generative chemistry to predict clinical resistance mutations and optimize small molecule therapeutics. This approach addresses the challenge of off-target interactions and enhances drug efficacy by tuning out toxic anti-targets while incorporating beneficial secondary targets.